| Literature DB >> 22513362 |
Yong-Won Kwon1, Il-Jin Kim, Di Wu, Jing Lu, William A Stock, Yueyong Liu, Yurong Huang, Hio Chung Kang, Reyno DelRosario, Kuang-Yu Jen, Jesus Perez-Losada, Guangwei Wei, Allan Balmain, Jian-Hua Mao.
Abstract
The Aurora-A kinase gene is frequently amplified and/or overexpressed in a variety of human cancers, leading to major efforts to develop therapeutic agents targeting this pathway. Here, we show that Aurora-A is targeted for ubiquitination and subsequent degradation by the F-box protein FBXW7 in a process that is regulated by GSK3β. Using a series of truncated Aurora-A proteins and site-directed mutagenesis, we identified distinct FBXW7 and GSK3β-binding sites in Aurora-A. Mutation of critical residues in either site substantially disrupts degradation of Aurora-A. Furthermore, we show that loss of Pten results in the stabilization of Aurora-A by attenuating FBXW7-dependent degradation of Aurora-A through the AKT/GSK3β pathway. Moreover, radiation-induced tumor latency is significantly shortened in Fbxw7(+/-)Pten(+/-) mice as compared with either Fbxw7(+/-) or Pten(+/-) mice, indicating that Fbxw7 and Pten appear to cooperate in suppressing tumorigenesis. Our results establish a novel posttranslational regulatory network in which the Pten and Fbxw7 pathways appear to converge on the regulation of Aurora-A level. 2012 AACREntities:
Mesh:
Substances:
Year: 2012 PMID: 22513362 PMCID: PMC3388112 DOI: 10.1158/1541-7786.MCR-12-0025
Source DB: PubMed Journal: Mol Cancer Res ISSN: 1541-7786 Impact factor: 5.852